Last Updated: February 11, 2026    
     

 
 
 
Featured Articles

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

NIH | December 10, 2024

HRSA HIV/AIDS Bureau Update: Special Bulletin 

HIV.gov | September 6, 2024

Lower Dose of Mpox Vaccine Is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen

NIH | April 27, 2024

Mpox cases in the US are on the rise as vaccination rates lag and new threats loom

CNN | March 28, 2024

HRSA Mpox Web Page
   
News Updates

Mpox Can Lead to Persistent Physical and Social Aftereffects

POZ | January 21, 2026

Hospitalization rate and patterns of clinical reasons among Mpox-confirmed cases: a systematic review and meta-analysis

Springer | January 22, 2026

Atypical Genital Mpox Mimicking a Sexually Transmitted Infection With Secondary Staphylococcus aureus Infection: A Case Report

Science Direct | January 20, 2026

Community-Led Responses to Mpox Among Gay, Bisexual, and Queer Men in Canada: Mapping the Collaboration of Community-Based...

NIH | January 19, 2026

Caring for Patients with Mpox

CDC | January 15, 2025

Monoclonal antibodies for Mpox: protective targets and therapeutic potential

Current Opinion in HIV and AIDS | January 19, 2026

Prior Mpox Infection Results in More Durable Protection Than MVA-BN Vaccination

Vaccine Advisor | January 13, 2026

P-218. Examining CD4, Viral Load and STI Co-Infection as Predictors of Severe Mpox Outcomes Among a Cohort of People with HIV in New York...

Oxford Academic | January 11, 2026

Mpox Immunity May Wane Over Time, Raising Questions for Long-Term Infection Prevention Planning

Infection Control Today | January 8, 2026

Prior mpox infection results in more durable protection than MVA-BN vaccination

EATG | January 7, 2026

Insights into host responses, viral evolution, and implications for vaccines and therapeutics for Mpox

NIH | January 6, 2026

Clinical characteristics of six fatal cases with advanced HIV and mpox virus co-infection in Beijing: a retrospective analysis

ScienceDirect | January 2, 2026

Mpox, Treponema pallidum co-infection in people with newly acquired HIV: A case series and literature review

Sage | December 23, 2025

Now is the time to launch mpox vaccine booster trials

STAT10 NEWS | December 11, 2025

Severe Anorectal Mpox With Newly Diagnosed HIV and Syphilis: A Diagnostic and Management Challenge

Cureus | December 8, 2025

Broader transmission of mpox due to clade Ib MPXV – Global situation

WHO | December 5, 2025

AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses

Nature | December 2, 2025

Associations Between Both HIV and Metabolic Comorbidity and Self-Reported Mpox Among Men Who Have Sex With Men: Multicenter...

NIH | December 1, 2025

Decoding cross-talk between Mpox and HIV: insights from transcriptomics and network-based analyses

Springer | December 1, 2025

Clade IIb Mpox Less Harmful in Infected Mice

IDSE | November 24, 2025

Optimal deployment of limited vaccine supplies to control mpox outbreaks

Nature | November 20, 2025

Central nervous system symptoms in mpox patients without HIV co-infection: A meta-analysis

Frontiers | November 18, 2025

Navigating the Mpox Outbreak: Insights on Vaccination Decisions and Psychosocial Impacts Among Gay, Bisexual, and Other Men Who Have Sex...

NIH | November 9, 2025

Patients With Mpox Face Racial Inequities and Delays in Tecovirimat Initiation

Vaccine Advisor | November 4, 2025

3 cases of new mpox strain reported in California

NPR | October 22, 2025

Predictors of Mpox-Related Hospitalization in Patients With HIV Coinfection

IDA | October 21, 2025

Virologic Rebounds Rare but Possible After Mpox Vaccination in People With HIV

IDSE | October 20, 2025

Considering the effects of pair formation dynamics on mpox and HIV co-infection in the gbMSM community

Scientific Reports | October 15, 2025

 

 
  2022 Archives 2023 Archives 2024 Archives 2025 Archives